oncovin
Oncovin (Vincristine Sulfate) is a medication used to treat Hodgkin Disease, Leukemia, Non-Hodgkin Lymphoma, Wilms Tumor.
Vincristine Sulfate · by Lilly
Available as a generic: Vincristine Sulfate
Key facts
- Active ingredient
- Vincristine Sulfate
- Form
- Injectable
- Strength
- Vincristine Sulfate 1MG/ML **Federal Register Determination That Product was not Discontinued or Withdrawn for Safety or Effectiveness reasons** · Vincristine Sulfate 1MG/VIAL **Federal Register Determination That Product was not Discontinued or Withdrawn for Safety or Effectiveness reasons** · Vincristine Sulfate 5MG/VIAL **Federal Register Determination That Product was not Discontinued or Withdrawn for Safety or Effectiveness reasons**
- Type
- Prescription (Rx)
- Brand or generic
- Brand-name
- May treat
- hodgkin disease, leukemia, non-hodgkin lymphoma
- Manufacturer
- Lilly
- FDA application
- NDA014103
- Availability
- Discontinued (per FDA)
May treat (source: NIH RxClass)
Dosage forms
Injectable
The forms currently marketed in the U.S., per the FDA National Drug Code Directory.
Ways to save
Ask for the generic
Same active ingredient, far cheaper. Is there a generic? →
Request a 90-day supply
Bulk fills usually lower the per-dose price vs monthly refills.
Use copay cards
Manufacturer copay cards & patient-assistance programs — especially for brand drugs.
Compare alternatives
A same-class option may cost less. See alternatives →
Frequently asked questions
- What does Oncovin treat?
- Oncovin (Vincristine Sulfate) may be used to treat hodgkin disease, leukemia, non-hodgkin lymphoma, wilms tumor, neuroblastoma, rhabdomyosarcoma, based on NIH RxClass drug-classification data (conditions a drug may treat — not a verbatim copy of the FDA-approved label). This is general reference, not medical advice.
- Is there a coupon or discount for Oncovin?
- pharmaranks is an independent ratings site, not a pharmacy — we don't issue coupons or sell Oncovin. To pay less, ask your prescriber or pharmacist whether a generic equivalent exists, check the manufacturer's copay/savings card and patient-assistance program, and compare a pharmacy discount card against your insurance copay. Prices vary by pharmacy, insurance, and location, so always confirm at the counter. This is general reference, not medical or financial advice.
- Who makes Oncovin?
- Oncovin is marketed by Lilly. You can see Lilly's full profile, rating, and other products on pharmaranks.
- Is Oncovin a brand-name or generic drug?
- Oncovin is a brand-name product with the active ingredient Vincristine Sulfate. Lower-cost generic equivalents containing Vincristine Sulfate are available — ask your pharmacist.
- Is Oncovin available over the counter?
- No. Oncovin is a prescription (Rx) medication in the US — you need a prescription from a licensed clinician (in person or via telehealth); it isn't sold over the counter. For some conditions there are OTC alternatives — ask your pharmacist.
- What forms does Oncovin come in?
- Oncovin is currently marketed as injectable, per the FDA's National Drug Code Directory.
- Is Oncovin FDA-registered?
- Oncovin is on record with the U.S. FDA under application number NDA014103. You can verify this on its official FDA label.
Information is sourced from public FDA regulatory data. Provided for general reference only — not medical advice. Always consult a licensed professional and the current prescribing information.
What people report to the FDA about VINCRISTINE SULFATE
The FDA Adverse Event Reporting System (FAERS) collects reports from patients and clinicians. It holds 29,840 reports naming VINCRISTINE SULFATE — the active ingredient in Oncovin, and the FDA flagged 97% of those reports as serious. The effects reported most often — leaving out reports about overdose, misuse or the condition being treated, which dominate the raw list for common medicines:
- febrile neutropenia4,492 reports
- pyrexia1,950 reports
- neutropenia1,787 reports
- sepsis1,122 reports
- vomiting1,047 reports
- nausea977 reports
- pancytopenia955 reports
- pneumonia951 reports
Read these as a signal, not a rate. A report does not mean VINCRISTINE SULFATE caused the effect — anyone can file one, and many describe people taking several medicines for several conditions. Crucially there is no denominator: FAERS does not record how many people took the drug, so these counts cannot be turned into “X% of patients” — a bigger number often just means a more widely used or more talked-about drug. Duplicates exist, and publicity drives reporting. For what is actually established, read the FDA label.
Source: openFDA drug/event (FAERS), retrieved September 26, 2026.
Reviews
No reviews yet. Be the first to write one.
People also viewed
cytarabine
Cytarabine
gleostine
Lomustine
gliadel
Carmustine
mozobil
Plerixafor
purinethol
Mercaptopurine
vivimusta
Bendamustine Hydrochloride
Compare Oncovin head-to-head
Browse medications A–Z
Research products from A to Z, compare independent ratings, and find alternatives.
oncovin
New